-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Boston Scientific, Lowers Price Target to $48

Benzinga·10/28/2026 17:43:41
Listen to the news
Needham analyst Mike Matson maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $57 to $48.